The business of cannabis provided investors with a wide variety of different news and developments. Virtually everyday investors had new progress from new stocks, legislation and policy, and the potential of new markets overseas.
During 2017 the Investing News Network (INN) covered various different aspects of the cannabis business. From new licenses to public launches and more, INN
Below, INN takes a look back at the five most-read cannabis stories of the year. Scroll down to take a look at the stories that caught the attention of INN’s investor audience during 2017.

US Election 2020 and Cannabis

Investing in cannabis? Read what experts have to say about cannabis and the US Election!

1. Supreme Receives Sales License, “It’s Been a Four Year Journey for Us,” Says President John Fowler

In July INN spoke with John Fowler, CEO of Supreme Pharmaceuticals (TSXV:FIRE) on the then recently obtained sales license under the Access to Cannabis for Medical Purposes Regulations (ACMPR) for their subsidiary 7ACRES.
“Getting the sales approval is obviously a large milestone day for Supreme. It’s something that we’ve been working on with the team at 7ACRES [since] the spring of 2013,” Fowler told INN.

2. Cannabis Wheaton President Talks Deal with ABcann and Facing Online Detractors

INN had the opportunity to chat with Hugo Alves the president of Cannabis Wheaton Income on his role in the company as at the time an incoming new member of the company. Alves talked about the potential the streaming model had for them.
“I think if we can execute this business model, our investors will be exceptionally well and that sort of negative noise will go away,” Alves told INN when asked about the negative comment the company had received online and its impact on the company.

3. Canopy Growth to be First Cannabis Stock on the S&P/TSX Composite Index

In March INN reported on Canopy Growth’s (TSX:WEED) inclusion healthcare sector of the S&P/TSX Composite Index (INDEXTSI:OSPTX). The announcement was significant because it signaled to a trend of the 2017 year for cannabis companies: an establishment in the market.
“In order to be eligible to list on the S&P/TSX Composite Index, companies must meet the certain market cap, liquidity and domicile requirements. They must also have been listed on the TSX for at least six months,” INN wrote.

US Election 2020 and Cannabis

Investing in cannabis? Read what experts have to say about cannabis and the US Election!

4. First Ever Cannabis ETF Officially Launches

Another maturity movement from the cannabis industry. In March we had questioned the possibility of a cannabis-focused exchange-traded funds (ETFs). Then a month later the Horizons Medical Marijuana Life Sciences ETF officially launched on the Toronto Stock Exchange (TSX).
The ETF currently has 10 holdings including Canopy Growth, Aurora Cannabis (TSX:ACB; OTCQB:ACBFF), Aphria (TSX:APH; OTC:APHQF) and MedReleaf (TSX:LEAF) amongst other cannabis stocks.

5. CSE Launches New Index, Cannabis Companies Show On Top

In September Canadian Securities Exchange (CSE) officially launched the CSE25 Index intended to largest companies on the exchange. From the initial group of companies, the top weighing companies were cannabis stocks.
The index included a variety of cannabis companies like Liberty Health Sciences (CSE:LHS), CannTrust Holdings (CSE:TRST) and CannaRoyalty (CSE:CRZ).
“[I]t is appropriate that we give market participants a benchmark that monitors the performance of our largest and most liquid issues,” Richard Carleton, CEO of the CSE said in the announcement.
Don’t forget to follow us @INN_LifeScience and @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less